Active Recombinant Human IFNL1 Protein

• Cat.No.: IFNL1-458H
• Product Overview: Recombinant human IFNL1 (NP_742152.1) (Met1-Thr200) was expressed with an initial Met.

Specification

• Species: Human
• Source: HEK293
• Tag: Non
• ProteinLength: 1-200 a.a.
• Predicted N Terminal: Met
• Form: Lyophilized from sterile PBS, pH 7.4, 5%~8% trehalose and mannitol.
• Bio-activity: Measured in antiviral assays using HepG2 cells infected with vesicular stomatitis virus. The ED50 for this effect is typically 10-39 ng/mL.
• Molecular Mass: The recombinant human IFNL1 consists 182 amino acids and predicts a molecular mass of 20.2 kDa.
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >(80.7+15.8) % as determined by SDS-PAGE.
• Stability: Samples are stable for up to twelve months from date of receipt at -70ºC.
• Storage: Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 ug/ul. Centrifuge the vial at 4℃ before opening to recover the entire contents.

Gene Information

• Gene Name: IFNL1 interferon, lambda 1 [ Homo sapiens ]
• Official Symbol: IFNL1
• Synonyms: IL29; IL-29; IFN-lambda-1; cytokine Zcyto21; interferon-lambda-1; interleukin 29 (interferon, lambda 1); interleukin-29
• Gene ID: 282618
• mRNA Refseq: NM_172140
• Protein Refseq: NP_742152
• MIM: 607403
• UniProt ID: Q8IU54
• Chromosome Location: 19q13.13
• Pathway: Cytokine-cytokine receptor interaction, organism-specific biosystem; Jak-STAT signaling pathway, organism-specific biosystem; Type III interferon signaling, organism-specific biosystem